Strategies for Improving Access to Cancer Services in Rural Communities: A Pre-implementation Study.

community-based participatory research multidisciplinary teams pre-implementation evaluation rural health stakeholder engagement workforce shortages

Journal

Frontiers in health services
ISSN: 2813-0146
Titre abrégé: Front Health Serv
Pays: Switzerland
ID NLM: 9918334887706676

Informations de publication

Date de publication:
2022
Historique:
received: 19 11 2021
accepted: 28 01 2022
entrez: 17 3 2023
pubmed: 18 3 2023
medline: 18 3 2023
Statut: epublish

Résumé

Implementation science is defined as the scientific study of methods and strategies that facilitate the uptake of evidence-based practice into regular use by practitioners. Failure of implementation is more common in resource-limited settings and may contribute to health disparities between rural and urban communities. In this pre-implementation study, we aimed to (1) evaluate barriers and facilitators for implementation of guideline-concordant healthcare services for cancer patients in rural communities in Upstate New York and (2) identify key strategies for successful implementation of cancer services and supportive programs in resource-poor settings. The mixed methods study was guided by the Consolidated Framework for Implementation Research (CFIR). Using engagement approaches from Community-Based Participatory Research, we collected qualitative and quantitative data to assess barriers and facilitators to implementation of rural cancer survivorship services (three focus groups, Responders reported preferences for cross-region team-based cancer care delivery and emphasized the importance of connecting local providers with cancer care networks and multidisciplinary teams at large urban cancer centers. The main reported barriers to rural cancer program implementation included regional variation in infrastructure and services delivery practices, inadequate number of providers/specialists, lack of integration among oncology, primary care and supportive services within the regions, and misalignment between clinical guideline recommendations and current reimbursement policies. Our findings revealed a unique combination of community, socio-economic, financial, and workforce barriers to implementation of guideline-concordant healthcare services for cancer patients in rural communities. One strategy to overcome these barriers is to improve provider cross-region collaboration and care coordination by means of teamwork and facilitation. Augmenting implementation framework with provider team-building strategies across and within regions could improve rural provider confidence and performance, minimize chances of implementation failure, and improve continuity of care for cancer patients living in rural areas.

Sections du résumé

Background UNASSIGNED
Implementation science is defined as the scientific study of methods and strategies that facilitate the uptake of evidence-based practice into regular use by practitioners. Failure of implementation is more common in resource-limited settings and may contribute to health disparities between rural and urban communities. In this pre-implementation study, we aimed to (1) evaluate barriers and facilitators for implementation of guideline-concordant healthcare services for cancer patients in rural communities in Upstate New York and (2) identify key strategies for successful implementation of cancer services and supportive programs in resource-poor settings.
Methods UNASSIGNED
The mixed methods study was guided by the Consolidated Framework for Implementation Research (CFIR). Using engagement approaches from Community-Based Participatory Research, we collected qualitative and quantitative data to assess barriers and facilitators to implementation of rural cancer survivorship services (three focus groups,
Results UNASSIGNED
Responders reported preferences for cross-region team-based cancer care delivery and emphasized the importance of connecting local providers with cancer care networks and multidisciplinary teams at large urban cancer centers. The main reported barriers to rural cancer program implementation included regional variation in infrastructure and services delivery practices, inadequate number of providers/specialists, lack of integration among oncology, primary care and supportive services within the regions, and misalignment between clinical guideline recommendations and current reimbursement policies.
Conclusions UNASSIGNED
Our findings revealed a unique combination of community, socio-economic, financial, and workforce barriers to implementation of guideline-concordant healthcare services for cancer patients in rural communities. One strategy to overcome these barriers is to improve provider cross-region collaboration and care coordination by means of teamwork and facilitation. Augmenting implementation framework with provider team-building strategies across and within regions could improve rural provider confidence and performance, minimize chances of implementation failure, and improve continuity of care for cancer patients living in rural areas.

Identifiants

pubmed: 36925773
doi: 10.3389/frhs.2022.818519
pmc: PMC10012790
doi:

Types de publication

Journal Article

Langues

eng

Pagination

818519

Informations de copyright

Copyright © 2022 Crabtree-Ide, Sevdalis, Bellohusen, Constine, Fleming, Holub, Rizvi, Rodriguez, Shayne, Termer, Tomaszewski and Noyes.

Déclaration de conflit d'intérêts

NS is the director of the London Safety and Training Solutions Ltd., which offers training in patient safety, implementation solutions, and human factors to healthcare organizations. LC reports royalties from UpToDate, Springer, Wolters-Kluwer, grant support from University of Alabama for Children's Oncology Survivorship Guidelines; all outside the submitted work. CC-I owns shares of Fortive Corporation and Danaher Corporation, outside of the submitted work. IR was employed by Mid-Atlantic Permanente Medical Group. NT was employed by Flatiron Healthcare Inc. KT was employed by KJT Group. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potentialconflict of interest.

Références

Soc Sci Med. 2012 Sep;75(6):986-9
pubmed: 22627017
Public Health. 2015 Jun;129(6):611-20
pubmed: 26025176
Asia Pac J Clin Oncol. 2019 Aug;15(4):199-207
pubmed: 31115170
Hum Factors. 2008 Jun;50(3):540-7
pubmed: 18689065
Implement Sci. 2015 Aug 07;10:109
pubmed: 26249843
Am Soc Clin Oncol Educ Book. 2017;37:695-704
pubmed: 28561689
Am Soc Clin Oncol Educ Book. 2014;:205-13
pubmed: 24857078
J Oncol Pract. 2015 May;11(3):247-8
pubmed: 25922220
J Oncol Pract. 2016 Nov;12(11):972-974
pubmed: 27756801
Am J Public Health. 2019 Jan;109(1):155-162
pubmed: 30496008
J Interprof Care. 2001 Aug;15(3):281-95
pubmed: 11705236
Psychiatr Serv. 2019 Dec 1;70(12):1157-1160
pubmed: 31434561
Cancer. 2018 Aug;124(16):3293-3306
pubmed: 30141837
Nurse Res. 2006 Jul 1;13(4):84
pubmed: 27702218
Eur Urol Focus. 2020 Sep 15;6(5):1097-1103
pubmed: 32534969
Oncol Nurs Forum. 2014 May;41(3):E211-9
pubmed: 24769604
Int J Environ Res Public Health. 2017 Jun 14;14(6):
pubmed: 28613257
Surg Oncol. 2011 Sep;20(3):146-54
pubmed: 21763127
J Thorac Oncol. 2013 May;8(5):549-53
pubmed: 23446202
Health Serv Res. 2012 Jun;47(3 Pt 2):1363-86
pubmed: 22353031
BMJ Qual Saf. 2013 May;22(5):369-73
pubmed: 23608882
Fam Med. 2015 Sep;47(8):604-11
pubmed: 26382118
Implement Sci Commun. 2020 Nov 4;1(1):97
pubmed: 33292813
Acad Emerg Med. 2008 Nov;15(11):1002-9
pubmed: 18828828
Am Soc Clin Oncol Educ Book. 2019 Jan;39:332-340
pubmed: 31099640
Health Aff (Millwood). 2019 Dec;38(12):2003-2010
pubmed: 31794316
J Oncol Pract. 2016 Nov;12(11):964-969
pubmed: 27858545
J Med Internet Res. 2021 Apr 5;23(4):e26960
pubmed: 33769942
J Oncol Pract. 2015 May;11(3):231-8
pubmed: 25873059
Am J Public Health. 2002 Apr;92(4):646-54
pubmed: 11919066
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
Annu Rev Public Health. 2000;21:639-57
pubmed: 10884968
Oncologist. 2011;16(8):1189-96
pubmed: 21765196
J Am Geriatr Soc. 2015 Feb;63(2):365-70
pubmed: 25640884
J Med Internet Res. 2020 Sep 9;22(9):e20786
pubmed: 32810841
JAMA. 2012 Apr 18;307(15):1587-8
pubmed: 22511684
BMJ Open. 2019 Jul 11;9(7):e028315
pubmed: 31300501
J Rural Health. 2014 Spring;30(2):206-13
pubmed: 24689545
Front Oncol. 2020 Mar 20;10:85
pubmed: 32266126
J Glob Oncol. 2016 Oct 5;3(5):658-665
pubmed: 29094102
J Natl Cancer Inst Monogr. 2010;2010(40):104-10
pubmed: 20386059
Cancer. 2020 Mar 1;126(5):1068-1076
pubmed: 31702829
Implement Sci. 2012 Jul 25;7:69
pubmed: 22831463
J Psychosoc Oncol. 2012;30(2):198-216
pubmed: 22416956
Ann R Coll Surg Engl. 2021 Jul;103(7):520-523
pubmed: 34192482
J Cancer Surviv. 2010 Jun;4(2):140-8
pubmed: 20099044
J Oncol Pract. 2016 Oct;12(10):e924-e932
pubmed: 27858564
J Oncol Pract. 2015 Jan;11(1):e19-27
pubmed: 25205779
Health Serv Res. 2019 Oct;54(5):994-1006
pubmed: 31215029
J Clin Oncol. 2021 Apr 20;39(12):1339-1348
pubmed: 33729825
BMJ Qual Saf. 2014 May;23(5):359-72
pubmed: 24501181
JAMA Netw Open. 2018 Aug 3;1(4):e181235
pubmed: 30646114
J Rural Health. 2013 Winter;29(1):61-8
pubmed: 23289656
CMAJ. 2016 Jul 12;188(10):E217-E227
pubmed: 27091801
Int J Technol Assess Health Care. 2010 Jul;26(3):334-40
pubmed: 20584364
J Nurs Manag. 2011 May;19(4):517-21
pubmed: 21569148
Med Care Res Rev. 2009 Dec;66(6 Suppl):5S-35S
pubmed: 19692553
Nurse Res. 2015 Sep;23(1):40-3
pubmed: 26365075
J Subst Abuse Treat. 2020 Jan;108:20-25
pubmed: 31399272
Transl Behav Med. 2018 Sep 8;8(5):683-691
pubmed: 30202926
J Natl Cancer Inst Monogr. 2010;2010(40):72-80
pubmed: 20386055
Cancer Epidemiol Biomarkers Prev. 2017 Jul;26(7):992-997
pubmed: 28600296
Clin Colon Rectal Surg. 2020 Jul;33(4):225-227
pubmed: 32624719
Cancer. 2013 Mar 1;119(5):1050-7
pubmed: 23096263
Ann Fam Med. 2015 Nov;13(6):554-61
pubmed: 26553895
JAMA Oncol. 2017 Jun 01;3(6):817-825
pubmed: 28125760

Auteurs

Christina Crabtree-Ide (C)

Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States.

Nick Sevdalis (N)

Center for Implementation Science, King's College London, London, United Kingdom.

Patricia Bellohusen (P)

Judy DiMarzo Cancer Survivorship Program, University of Rochester, Rochester, NY, United States.

Louis S Constine (LS)

Department of Radiation Oncology, Wilmot Cancer Institute, Rochester, NY, United States.

Fergal Fleming (F)

Surgical Health Outcomes & Research Enterprise (SHORE), University of Rochester Medical Center, Rochester, NY, United States.

David Holub (D)

Department of Family Medicine, University of Rochester, Rochester, NY, United States.

Irfan Rizvi (I)

Mid-Atlantic Permanente Medical Group, McLean, VA, United States.

Jennifer Rodriguez (J)

Livingston County Public Health Department, Mt. Morris, NY, United States.

Michelle Shayne (M)

Department of Family Medicine, University of Rochester, Rochester, NY, United States.

Nancy Termer (N)

Flatiron Healthcare Inc., New York, NY, United States.

Ken Tomaszewski (K)

KJT Group, Honeoye Falls, NY, United States.

Katia Noyes (K)

Department of Epidemiology and Environmental Health, University at Buffalo, Buffalo, NY, United States.

Classifications MeSH